The Voice of the Community

NPR's Ari Shapiro speaks with Dr. Robert Wachter about the latest round of FDA-approved COVID-19 boosters and how people should think about the coronavirus and its risk.

Three years ago, the emergency declaration enabled certain tools for fighting the pandemic and protecting Americans. Now that it's expiring, here's what is changing — and what's not.

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.

And what about a cold or RSV? With all the illness spreading, it's virus soup out there these days. Some people feel so sick they're wondering if they're fighting more than one germ at once.

You'll see testing in some airports these days — it's just like we're going back in time! And speaking of looking back, the things that protected fliers from COVID then are still a good idea.

Let's revisit some of 2022's still relevant queries. Like: Does one-way masking help? What's the risk of outdoor transmission? What's up with faint lines on tests?

As the holiday approaches, infectious disease specialists are bracing for the possibility that big family get-togethers and travel will propel the spread of RSV, flu and COVID-19.

SARS-CoV-2 is evolving "rapidly," spawning one new variant after another. But omicron continues to dominate, raising new questions about how evolution of the virus is headed.

More Than 522K Receive Booster